Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Medtronic
AstraZeneca
Harvard Business School
McKinsey

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Litigation Details for Mayne Pharma International Pty Ltd. v. Actavis Elizabeth LLC (D. Del. 2017)

See Plans and Pricing

« Back to Dashboard

Mayne Pharma International Pty Ltd. v. Actavis Elizabeth LLC (D. Del. 2017)

Docket   Start Trial Date Filed 2017-11-09
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To
Jury Demand None Referred To
Parties ACTAVIS ELIZABETH LLC; LUPIN ATLANTIS HOLDINGS SA; LUPIN INC.; LUPIN LIMITED; LUPIN PHARMACEUTICALS, INC.; MAYNE PHARMA INTERNATIONAL PTY LTD.; TEVA PHARMACEUTICALS USA, INC.
Patents 6,958,161; 9,295,652; 9,446,057; 9,511,031
Attorneys Chandrika Vira; Chanson Chang; Claire A. Fundakowski; David A. Bilson; George F. Pappas; Jack B. Blumenfeld; James L. Higgins; John C. Phillips , Jr.; John C. Rozendaal; Kurt A. Mathas; Maryellen Noreika; Megan Elizabeth Dellinger; Melanie K. Sharp; Michael K. Nutter; Michael N. Kennedy; Pauline M Pelletier; Ryan B. Hauer; Yiye Fu
Firms Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Mayne Pharma International Pty Ltd. v. Actavis Elizabeth LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Mayne Pharma International Pty Ltd. v. Actavis Elizabeth LLC (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-11-09 1 expiration of United States Patent No. 6,958,161 (“the ’161 Patent”); United States Patent No. 9,295,652 (“the…’652 Patent”); United States Patent No. 9,446,057 (“the ’057 Patent”); and United States Patent No. 9,511,031…infringement of the ’161 Patent, the ’652 Patent, the ’057 Patent, and the ’031 Patent. 12. This…Mayne owns the ’161 Patent, the ’652 Patent, the ’057 Patent, and the ’031 Patent. … 23. The ’161 Patent, the ’652 Patent, the ’057 Patent, and the ’031 Patent are listed in the Approved External link to document
2017-11-09 3 or about 10/2/2017. Date of Expiration of Patent: 6,958,161 - 12/12/2022; 9,295,652 - 10/23/2034; 9,446,057… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 9 November 2017 1:17-cv-01614 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
2017-11-09 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,958,161 B2; 9,295,652 B1; 9,446,057… 9 November 2017 1:17-cv-01614 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 98 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,958,161 B2; 9,295,652 B1; 9,446,057…2017 23 January 2019 1:17-cv-01614 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Boehringer Ingelheim
Johnson and Johnson
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.